In vitro studies of the neuroprotective activities of astaxanthin and fucoxanthin against amyloid beta (Aβ1-42) toxicity and aggregation
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Amyloid beta (A&bgr;) can aggregate and form plaques, which are considered as one of the major hallmarks of Alzheimer's disease. This study aims to directly compare the neuroprotective activities in vitro of two marine‐derived carotenoids astaxanthin and fucoxanthin that have shown a spectrum of biological activities, including neuroprotection. The in vitro neuroprotective activities were investigated against A&bgr;1–42‐mediated toxicity in pheochromocytoma (PC‐12) neuronal cells using the MTT cell viability assay, anti‐apoptotic, antioxidant and neurite outgrowth activities; as well as inhibition against A&bgr;1–42 fibrillization in the Thioflavin T (ThT) assay of fibril kinetics and via transmission electron microscopic (TEM) evaluation of fibril morphology. The results demonstrated that both astaxanthin and fucoxanthin exhibited multi‐neuroprotective effects favouring fucoxanthin over astaxanthin supporting neuroprotective roles of marine‐derived carotenoids as potential novel dementia prevention or therapeutic strategies. HIGHLIGHTSAstaxanthin and fucoxanthin provided neuroprotection against A&bgr;1–42.Both compounds showed anti‐aggregation effects against A&bgr;1–42.Both compounds demonstrated multiple neuroprotective activities.Fucoxanthin showed higher anti‐aggregation and neurite outgrowth activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
2018 Alzheimer's disease facts and figures
Alzheimer's Association (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.001 · Cited by 1,912
Alzheimer’s disease drug-development pipeline: Few candidates, frequent failures
Cummings, J. L., Morstorf, T., & Zhong, K. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt269 · Cited by 1,744 · cited 1×
“aspartate (NMDA) receptor (memantine) have been approved to reduce some symptoms experienced by AD sufferers (Cummings et al., 2014).”
Haematococcus astaxanthin: applications for human health and nutrition
Guerin, M., Huntley, M. E., & Olaizola, M. (2003) · Trends in Biotechnology · doi:10.1016/s0167-7799(03)00078-7 · Cited by 1,495
Astaxanthin: a review of its chemistry and applications
Higuera-Ciapara, I., Félix-Valenzuela, L., & Goycoolea, F. M. (2006) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408690590957188 · Cited by 1,287
Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase
Hussain, I., Powell, D., Howlett, D. R., Tew, D. G., Meek, T. D., Chapman, C., Gloger, I. S., Murphy, K. E., Southan, C. D., Ryan, D. M., et al. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0811 · Cited by 1,080
Nerve Growth Factor Treatment After Brain Injury Prevents Neuronal Death
Kromer, L. F. (1987) · Science · doi:10.1126/science.3798108 · Cited by 932 · cited 1×
“It was found that decreasing the level of nerve growth factor (NGF) can result in neuronal dysfunction (Hefti and Weiner, 1986), while NGF can increase neuronal survival (Kromer, 1987).”
Peng, J., Yuan, J.-P., Wu, C.-F., & Wang, J.-H. (2011) · Marine Drugs · doi:10.3390/md9101806 · Cited by 820 · cited 1×
“1b) is a carotenoid (also known as tetraterpenoid) derived from brown algae and microalgae (Peng et al., 2011).”
Testing the Right Target and Right Drug at the Right Stage
Sperling, R. A., Jack, C. R., & Aisen, P. S. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002609 · Cited by 550
Sachindra, N. M., Sato, E., Maeda, H., Hosokawa, M., Niwano, Y., Kohno, M., & Miyashita, K. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf071848a · Cited by 516 · cited 1×
“5 times higher activity than previously reported for α-tocopherol in hydroxyl radical-scavenging assay (Sachindra et al., 2007).”
Cited by
Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Dominguez, L., Shea, J.-E., Dokholyan, N. V., De Simone, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 678
Kazemi Shariat Panahi, H., Dehhaghi, M., Ok, Y. S., Nizami, A.-S., Khoshnevisan, B., Mussatto, S. I., Aghbashlo, M., Tabatabaei, M., & Lam, S. S. (2020) · Journal of Cleaner Production · doi:10.1016/j.jclepro.2020.122462 · Cited by 483
Microalgae-Derived Pigments: A 10-Year Bibliometric Review and Industry and Market Trend Analysis
Silva, S. C., Ferreira, I. C. F. R., Dias, M. M., & Barreiro, M. F. (2020) · Molecules · doi:10.3390/molecules25153406 · Cited by 248
Shehata, M. K., Ismail, A. A., & Kamel, M. A. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s417928 · Cited by 55
Natural Products from Plants and Algae for Treatment of Alzheimer’s Disease: A Review
Klose, J., Griehl, C., Roßner, S., & Schilling, S. (2022) · Biomolecules · doi:10.3390/biom12050694 · Cited by 23
Metadata
- Authors
- Alghazwi, M., Smid, S., Musgrave, I., & Zhang, W.
- Venue
- Neurochemistry International
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 124
- Pages
- 215-224
- ISSN
- 0197-0186 (ISSN-L)
- OpenAlex
- W2910079715
- Cited by
- 115
- References
- 14
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.